SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-051086
Filing Date
2022-02-24
Accepted
2022-02-24 07:31:41
Documents
5
Effectiveness Date
2022-02-24

Document Format Files

Seq Description Document Type Size
1 S-8 d297315ds8.htm S-8 37634
2 EX-5.1 d297315dex51.htm EX-5.1 6716
3 EX-23.1 d297315dex231.htm EX-23.1 1718
4 EX-FILING FEES d297315dexfilingfees.htm EX-FILING FEES 18420
5 GRAPHIC g297315g0223101010682.jpg GRAPHIC 2668
  Complete submission text file 0001193125-22-051086.txt   69344
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262947 | Film No.: 22666535
SIC: 2836 Biological Products, (No Diagnostic Substances)